Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-29T11:58:09.289Z Has data issue: false hasContentIssue false
  • English
  • Français

Trends in methicillin-resistant Staphylococcus aureus bloodstream infections using statewide population-based surveillance and hospital discharge data, Connecticut, 2010–2018

Published online by Cambridge University Press:  13 April 2020

Ashley N Rose Open the ORCID record for Ashley N Rose [Opens in a new window] ,
Paula Clogher ,
Kelly M Hatfield ,
Runa H Gokhale ,
Isaac See  and
Susan Petit
Ashley N Rose*
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Paula Clogher
Affiliation:
Yale University, New Haven, Connecticut
Kelly M Hatfield
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Runa H Gokhale
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Isaac See
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Susan Petit
Affiliation:
Connecticut Department of Public Health, Hartford, Connecticut
*
Author for correspondence: Ashley Rose, E-mail: OUM0@cdc.gov
Get access Rights & Permissions [Opens in a new window]

Abstract

We compared methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) captured by culture-based surveillance and MRSA septicemia hospitalizations captured by administrative coding using statewide hospital discharge data in Connecticut from 2010 to 2018. Observed discrepancies between identification methods suggest administrative coding is inappropriate for assessing trends in MRSA BSIs.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 6 , June 2020 , pp. 734 - 736
Creative Commons
Creative Common License - CCCreative Common License - BY
This work is classified, for copyright purposes, as a work of the U.S. Government and is not subject to copyright protection within the United States.
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kourtis, AP, Hatfield, K, Baggs, J, et al.Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States. Morb Mortal Wkly Rep 2019;68:214–219.CrossRefGoogle ScholarPubMed
Dantes, R, Mu, Y, Belflower, R, et al.National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013;173:1970–1978.Google ScholarPubMed
Schaefer, M, Ellingson, K, Conover, C, et al.Evaluation of International Classification of Diseases, Ninth Revision, Clinical Modification codes for reporting methicillin-resistant Staphylococcus aureus infections at a hospital in Illinois. Infect Control Hosp Epidemiol 2010;31:463–468.CrossRefGoogle Scholar
Schweizer, ML, Eber, MR, Laxminarayan, R, et al.Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol 2011;32:148–154.CrossRefGoogle ScholarPubMed
David, MZ, Medvedev, S, Hohmann, SF, Ewigman, B, Daum, RS. Increasing burden of methicillin-resistant Staphylococcus aureus hospitalizations at US academic medical centers, 2003–2008. Infect Control Hosp Epidemiol 2012;33:782–789.CrossRefGoogle ScholarPubMed
Klein, E, Sun, L, Smith, DL, Laxminarayan, R. The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol 2013;177:666–674.CrossRefGoogle ScholarPubMed
Klein, EY, Mojica, N, Jiang, W, et al.Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010–2014. Clin Infect Dis 2017;65: 1921–1923.CrossRefGoogle ScholarPubMed
Inagaki, K, Lucar, J, Blackshear, C, Hobbs, CV. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 2019;69:2112–2118.Google Scholar
Novosad, SA, Sapiano, MR, Grigg, C, et al.Vital signs: epidemiology of sepsis: prevalence of healthcare factors and opportunities for prevention. Morb Mortal Wkly Rep 2016;65:864–869.CrossRefGoogle Scholar
Rhee, C, Dantes, R, Epstein, L, et al.Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA 2017;318:1241–1249.CrossRefGoogle Scholar
Supplementary material: PDF

Rose et al. supplementary material

Rose et al. supplementary material

Download Rose et al. supplementary material(PDF)
PDF 133.2 KB